Key Statistics
About Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Feb 20, 2026 | Barclays | |
| Feb 9, 2026 | Deutsche Bank | |
| Feb 5, 2026 | Cantor Fitzgerald | |
| Feb 5, 2026 | JP Morgan | |
| Feb 5, 2026 | Wells Fargo |